What is the long-term trend for ADMA Biologics's common stock, par value (in dollars per share)?

Over 5 years (2020 to 2025), ADMA Biologics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.

ADMA Biologics ADMA Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

ZymeworksZYME

——

AbbVieABBV

——

AmgenAMGN

——

DanaherDHR

——

Charles River LaboratoriesCRL

——

HaemoneticsHAE

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's common stock, par value (in dollars per share)?: ADMA Biologics (ADMA) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has ADMA Biologics's common stock, par value (in dollars per share) changed year-over-year?: ADMA Biologics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for ADMA Biologics's common stock, par value (in dollars per share)?: Over 5 years (2020 to 2025), ADMA Biologics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.